DOC
Healthpeak Properties, Inc. Real Estate - REIT - Healthcare Facilities Investor Relations →
Healthpeak Properties, Inc. (DOC) closed at $19.56 as of 2026-06-19, trading 11.2% above its 200-week moving average of $17.60. The stock is currently moving closer to the line, down from 16.9% last week. The 14-week RSI sits at 66, indicating neutral momentum.
Trading volume is running at 0.9x of its 14-week average, which is in the normal range. The balance between buying and selling volume (0.87 ratio) is neutral — neither side is clearly dominating.
Over the past 2095 weeks of data, DOC has crossed below its 200-week moving average 19 times. On average, these episodes lasted 25 weeks. Historically, investors who bought DOC at the start of these episodes saw an average one-year return of +6.1%.
With a market cap of $13.5 billion, DOC is a large-cap stock. The company generates a free cash flow yield of 8.2%, which is notably high. Return on equity stands at 2.8%. The stock trades at 1.7x book value.
Share count has increased 27.1% over three years, indicating dilution.
Over the past 33.5 years, a hypothetical investment of $100 in DOC would have grown to $1319, compared to $3097 for the S&P 500. DOC has returned 8.0% annualized vs 10.8% for the index, underperforming the broader market over this period.
Free cash flow has been growing at a 11.6% compound annual rate, with 4 consecutive years of positive cash generation.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: DOC vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After DOC Crosses Below the Line?
Across 17 historical episodes, buying DOC when it crossed below its 200-week moving average produced an average return of +3.9% after 12 months (median -1.0%), compared to +16.6% for the S&P 500 over the same periods. 47% of those episodes were profitable after one year. After 24 months, the average return was +17.6% vs +23.4% for the index.
Each line shows $100 invested at the moment DOC crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Bean Score Experimental
The Bean Score measures how far a stock's free cash flow yield has deviated from its own quarterly baseline, normalized by the stock's historical behavior. Between earnings dates, FCF is constant — so the score is purely a function of stock price. The levels below show at what prices DOC would reach each dislocation threshold.
Dislocation Price Levels
Prices where DOC's Bean Score would hit each σ threshold. Valid until next earnings report: 2026-07-23.
| Level | σ | Price | Signal |
|---|---|---|---|
| Deep Value | +2σ | $15.88 | Unusually cheap — potential buy zone |
| Value | +1σ | $16.74 | Cheap vs. own history |
| Fair Value | +0σ | $17.71 | Historical mean behavior |
| Expensive | -1σ | $18.80 | Expensive vs. own history |
| Deep Expensive | -2σ | $20.03 | Unusually expensive — potential trim zone |
Quarterly FCF & Yield Trailing twelve-month free cash flow and yield at each quarter end
Signal Accuracy Collecting Data
The Bean Score system is accumulating weekly data to validate signal accuracy. After 13+ weeks of history, this section will display win rates and average returns for each σ threshold crossing — answering the question: "When this score says cheap or expensive, does the price subsequently move in the expected direction?"
Theoretical framework — not backtested or forward-tested. The Bean Score uses trailing twelve-month free cash flow yield as a dislocation identifier. It measures whether the market has pushed a stock's yield unusually far from its own baseline behavior. These levels are reference points for identifying potential swing trade opportunities, not buy/sell signals. FCF values update quarterly with earnings; between reports, all movement is price-driven.
Dislocation Scores Experimental
Each score measures deviation from DOC's own historical baseline — the same idea as the Bean Score, applied to different fundamentals. Positive means cheaper or more dislocated than this stock's norm. Scores marked σ are normalized by the stock's own variability; pp values are simple deltas from its recent baseline.
Theoretical framework — not backtested. These scores describe how unusual today's readings are for this specific company. They are starting points for research, not buy or sell signals. Annual-statement scores (buyback, accruals, FCF vs history) rest on only ~4 yearly data points and are deltas, not sigmas.
Historical Touches
DOC has crossed below its 200-week MA 19 times with an average 1-year return of +6.1% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Sep 1987 | Oct 1987 | 3 | 4.5% | +30.9% | +4875.7% |
| Oct 1987 | Nov 1987 | 2 | 1.4% | +23.9% | +4720.2% |
| Dec 1998 | Dec 1998 | 2 | 2.2% | -18.4% | +693.6% |
| Jan 1999 | Mar 1999 | 7 | 10.0% | -5.0% | +687.0% |
| Mar 1999 | Apr 1999 | 4 | 4.3% | -2.3% | +688.6% |
| May 1999 | May 2000 | 49 | 21.3% | +4.3% | +668.0% |
| Oct 2008 | Aug 2009 | 41 | 40.2% | +18.4% | +107.0% |
| Dec 2013 | Jan 2014 | 4 | 2.3% | +33.7% | +17.8% |
| Mar 2014 | Mar 2014 | 1 | 0.1% | +21.1% | +12.7% |
| Jun 2015 | Aug 2015 | 10 | 4.3% | -4.3% | +4.1% |
| Aug 2015 | Oct 2015 | 6 | 7.0% | +9.4% | +1.7% |
| Oct 2015 | Jul 2016 | 37 | 30.1% | -2.3% | +3.0% |
| Oct 2016 | Feb 2017 | 20 | 14.8% | -13.6% | +0.3% |
| Mar 2017 | Apr 2017 | 4 | 5.9% | -19.8% | +7.5% |
| Apr 2017 | May 2017 | 2 | 4.4% | -21.4% | +2.1% |
| Jul 2017 | Oct 2018 | 65 | 25.9% | -6.0% | +5.9% |
| Mar 2020 | Jun 2020 | 11 | 25.7% | +60.4% | +30.9% |
| Jun 2020 | Jul 2020 | 6 | 1.8% | +31.5% | +2.6% |
| May 2022 | May 2026 | 205 | 38.4% | -24.2% | -13.1% |
| Average | 25 | — | +6.1% | — |
Frequently Asked Questions
Is DOC below its 200-week moving average?
No. Healthpeak Properties, Inc. (DOC) is currently 11.2% above its 200-week moving average of $17.60. It would need to fall to $17.60 to cross below the line.
What is DOC's 200-week moving average price?
Healthpeak Properties, Inc.'s 200-week moving average is $17.60 as of 2026-06-19. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when DOC drops below its 200-week moving average?
DOC has crossed below its 200-week moving average 19 times in our data. On average, buying at that moment produced a one-year return of +6.1%. These dips have historically been decent entry points. These episodes lasted 25 weeks on average.
Is DOC a good value right now?
Here's what our data says about DOC as of 2026-06-19: The stock is above its 200-week moving average, so it doesn't currently meet our primary signal. The 14-week RSI is 66. Free cash flow yield is 8.2%. Return on equity is 2.8%. Price-to-book is 1.7x. This is not a buy or sell recommendation — always do your own research.
How does DOC compare to the S&P 500?
Over the past 33.5 years, $100 invested in DOC would have grown to $1319, compared to $3097 for the S&P 500. That's 8.0% annualized vs 10.8% for the index. DOC has underperformed the broader market over this period.
Does DOC pay a dividend?
Yes. Healthpeak Properties, Inc. currently pays a dividend yield of 607.00%.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-06-19